Flagship Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Flagship Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.48K	Hold	59	–	–	﹤0.01%	458
2026 Q1	$1.44K	Hold	59	–	–	﹤0.01%	339
2025 Q4	$1.71K	Hold	59	–	–	﹤0.01%	375
2025 Q3	$1.64K	Hold	59	–	–	﹤0.01%	394
2025 Q2	$1.44K	Hold	59	–	–	﹤0.01%	354
2025 Q1	$1.23K	Hold	59	–	–	﹤0.01%	361
2024 Q4	$1.39K	Buy	+59	New	+$1.45K	﹤0.01%	355

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Flagship Wealth Advisors's ARKG Position: Q2 2026 in Review

Flagship Wealth Advisors held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 59 shares worth $2.48K. The position accounts for ﹤0.01% of the portfolio, ranked #458.

Flagship Wealth Advisors first reported a position in ARKG in Q4 2024 and has held it in 7 quarters since. 274 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Flagship Wealth Advisors held 59 shares of ARK Genomic Revolution ETF worth $2.48K as of Q2 2026.
Flagship Wealth Advisors left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Flagship Wealth Advisors's portfolio in Q2 2026, its #458 holding.
Flagship Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 7 quarters since.
274 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Flagship Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.